Choate Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,292
Closed -$794K 328
2022
Q1
$794K Buy
+10,292
New +$794K 0.04% 164